Our results highlight an important need in patients with cancer to help prevent DKA, though proactive counseling, active monitoring of glucose for cancer patients with known diabetes receiving therapies known to cause hyperglycemia, and anticipatory adjustments to insulin therapy for patients placed on high dose steroids. The gene discussed is INS; the disease is Hyperglycemia.